UNSPSC 51283906: Sulfabenzamide

This classification denotes a sulfonamide anti-infective agent with the molecular formula C13H12N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G58F8OPL4I, chemically known as sulfanilamide, n(sup1)-benzoyl- but generally known as sulfabenzamide, which bears US NIH Compound Identifier 5319. European Medicines Agency schedules Sulfabenzamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10684MIG.

UNSPSC 51283906 Sulfabenzamide is a Commodity code for a specific pharmaceutical active ingredient, but state and local procurement activity under this code shows little relevant recent activity. The two most recent opportunities posted under or adjacent to this code — a piggyback pharmaceutical warehouse contract awarded by the Illinois Department of Public Health for antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and a Seminole County, Florida procurement for Naloxone and drug deactivation systems — do not match the sulfabenzamide scope. State and local health departments and county health agencies do source pharmaceuticals through cooperative purchasing vehicles such as MMCAP Infuse and direct competitive bidding, typically with quarterly or annual delivery cycles and fixed-fee pricing models, but the recent record does not show active solicitation specifically for sulfabenzamide or closely related sulfonamide drugs.

Geographic activity when present spans state health departments (Illinois) and county-level health and emergency-response agencies (Florida), though the sparse recent record prevents characterization of concentration or trend. No open solicitations for sulfabenzamide appear in the recent pipeline; the Illinois award was completed as of August 28, 2026, and the Seminole County opportunity referenced a July 26, 2023 response deadline now historical. Vendors in pharmaceutical supply chains should monitor state formulary updates, emergency preparedness purchasing programs, and cooperative purchasing consortia for sulfabenzamide opportunities, but current velocity under this Commodity code is low.